tiprankstipranks
Recursion Pharmaceuticals (RXRX)
NASDAQ:RXRX
US Market
RXRX
Recursion Pharmaceuticals
RESEARCH TOOLSreports

Recursion Pharmaceuticals (RXRX) Stock News & Sentiment

4,431 Followers
Recursion Pharmaceuticals Names New Chief Medical Officer
Premium
Company Announcements
Recursion Pharmaceuticals Names New Chief Medical Officer
19d ago
8K
RXRX
Insiders Cash Out: GE Vernova, Recursion, Axon, Seagate, Energy Fuels
Premium
Weekend Updates
Insiders Cash Out: GE Vernova, Recursion, Axon, Seagate, Energy Fuels
1M ago
GEV
STX
Recursion Pharmaceuticals’ Earnings Call Highlights AI Momentum
Premium
Company Announcements
Recursion Pharmaceuticals’ Earnings Call Highlights AI Momentum
1M ago
RXRX
Balanced Risk-Reward Keeps Recursion at Hold as Key Clinical Catalysts Remain Longer-Dated
Premium
Ratings
Balanced Risk-Reward Keeps Recursion at Hold as Key Clinical Catalysts Remain Longer-Dated
2M ago
RXRX
Recursion Highlights AI Validation, Extends Cash Runway to 2028
Premium
Company Announcements
Recursion Highlights AI Validation, Extends Cash Runway to 2028
2M ago
8K
RXRX
Cathie Wood Invests $3M in CoreWeave Stock Ahead of Earnings and Adds $8.7M in Figma, Trims Exposure in DKNG
Premium
Market News
Cathie Wood Invests $3M in CoreWeave Stock Ahead of Earnings and Adds $8.7M in Figma, Trims Exposure in DKNG
2M ago
PD
DSY
Recursion Pharmaceuticals, Inc (RXRX) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Recursion Pharmaceuticals, Inc (RXRX) Q4 Earnings Cheat Sheet
2M ago
RXRX
More RXRX News >

RXRX News on the Web

Recursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for Investors
Zacks
Neutral
Insider Sell Alert: Blake Borgeson Sells 30,000 Shares of Recursion Pharmaceuticals Inc (RXRX)
GuruFocus News
Neutral
Largest borrow rate increases among liquid names
TipRanks News
Neutral
Recursion Pharmaceuticals (RXRX) Beats Stock Market Upswing: What Investors Need to Know
Zacks
Bullish
Goldman is betting Nvidia will get a boost from health care as industry builds out AI capabilities
CNBC
Neutral
Here's Why Recursion Pharmaceuticals (RXRX) Fell More Than Broader Market
Zacks
Bearish
Recursion Pharmaceuticals (RXRX) Down 16.5% Since Last Earnings Report: Can It Rebound?
Zacks
Bearish
Recursion Pharmaceuticals Names New Chief Medical Officer
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
RXRX
Sector Average
Media Buzz
This Week3 articles
Weekly Average3.25 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RXRX’s Media Buzz Sentiment?
3 articles about RXRX were published this week. In an average week, 3.25 articles are published.
    What is RXRX’s weekly average amount of articles?
    In an average week, 3.25 articles about RXRX are published.
      What is RXRX’s News Sentiment?
      50% of articles about RXRX were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        STAAStaar Surgical
        IVVDInvivyd
        SLPSimulations Plus
        REPLReplimune Group
        Showing the stocks with the most bullish news sentiment over the past week